ev-pure
Biologicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2022 (NCT05387239)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- AdipocytesSupplementation
Adipocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06072794 | Phase 1 | Oct 6, 2023 | Vitti Labs, LLC |
| NCT05387278 | Phase 1 | Mar 20, 2023 | Vitti Labs, LLC |
| NCT05387239 | Phase 1 | Nov 30, 2022 | Vitti Labs, LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vitti Labs, LLC | For profit | 3 | 3 | 1 | 2022 |
1 organizations
Page 1 / 1